In response to the urgent need for paediatric data comparing the two new variant A/H1N1 vaccines in the UK before the onset of a second wave of flu,1 and a call for proposals related to new variant A/H1N1 by the National Institute for Health Research (NIHR),2 we designed a clinical trial of immunogenicity and tolerability in children aged 6 months-12 years. We submitted a collaborative funding application to NIHR on 24 July 2009, receiving an award letter on 1 September. We redeployed trials staff, funded variously by the agencies given in this letter, to prepare submissions for ethical, regulatory, and NHS research and development approval.
No takes yet. Share an insight, caveat, or question.
Pollard et al. (2009) studied this question.